Immunohistochemical detection of overexpression of CLU in early-stage (stage I/II) ovarian cancer tissues was significantly related to poor survival, while none of other clinicopathological factors analyzed were related to survival. The gene discussed is CLU; the disease is ovarian carcinoma.